Protagenic Therapeutics, Inc.Protagenic Therapeutics, Inc.Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc.

No trades
See on Supercharts

PTIX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PTIX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company